Author Correction: c-Kit-positive ILC2s exhibit an ILC3-like signature that may contribute to IL-17-mediated pathologies

Affiliations

• ¹ Department of Experimental Immunology, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands.
• ² Department of Respiratory, Inflammation and Autoimmunity, MedImmune LLC, Gaithersburg, MD, USA.
• ³ Department of Dermatology, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands.
• ⁴ Department of Research Bioinformatics, MedImmune LLC, Gaithersburg, MD, USA.
• ⁵ Autoimmunity, Transplantation, and Inflammation Disease Area, Novartis Institutes for BioMedical Research, Basel, Switzerland.
• ⁶ Department of Oncogenomics, Academic Medical Center, Amsterdam, the Netherlands.
• ⁷ Department of Translational Medicine and Pharmacogenomics, MedImmune LLC, Gaithersburg, MD, USA.
• ⁸ Department of Experimental Immunology, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands. [email protected].
• ⁹ Department of Respiratory, Inflammation and Autoimmunity, MedImmune LLC, Gaithersburg, MD, USA. [email protected].